Rehavi M - Search Results

1

Biochemical and pharmacological characterization of the serotonin transporter in human peripheral blood lymphocytes.

Barkan T, Gurwitz D, Levy G, Weizman A, Rehavi M. Barkan T, et al. Among authors: rehavi m. Eur Neuropsychopharmacol. 2004 May;14(3):237-43. doi: 10.1016/S0924-977X(03)00107-X. Eur Neuropsychopharmacol. 2004. PMID: 15056483

2

Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2.

Rehavi M, Roz N, Weizman A. Rehavi M, et al. Eur Neuropsychopharmacol. 2002 Jun;12(3):261-8. doi: 10.1016/s0924-977x(02)00021-4. Eur Neuropsychopharmacol. 2002. PMID: 12007678

3

Increased platelet vesicular monoamine transporter density in adult schizophrenia patients.

Zucker M, Valevski A, Weizman A, Rehavi M. Zucker M, et al. Among authors: rehavi m. Eur Neuropsychopharmacol. 2002 Aug;12(4):343-7. doi: 10.1016/s0924-977x(02)00041-x. Eur Neuropsychopharmacol. 2002. PMID: 12126874

4

Decreased platelet vesicular monoamine transporter density in children and adolescents with attention deficit/hyperactivity disorder.

Toren P, Rehavi M, Luski A, Roz N, Laor N, Lask M, Weizman A. Toren P, et al. Among authors: rehavi m. Eur Neuropsychopharmacol. 2005 Mar;15(2):159-62. doi: 10.1016/j.euroneuro.2004.07.002. Eur Neuropsychopharmacol. 2005. PMID: 15695060

5

Repeated swim stress leads to down-regulation of vesicular monoamine transporter 2 in rat brain nucleus accumbens and striatum.

Zucker M, Weizman A, Rehavi M. Zucker M, et al. Among authors: rehavi m. Eur Neuropsychopharmacol. 2005 Mar;15(2):199-201. doi: 10.1016/j.euroneuro.2004.08.009. Eur Neuropsychopharmacol. 2005. PMID: 15695065

6

Decreased platelet vesicular monoamine transporter density in habitual smokers.

Schwartz K, Weizman A, Rehavi M. Schwartz K, et al. Among authors: rehavi m. Eur Neuropsychopharmacol. 2005 Mar;15(2):235-8. doi: 10.1016/j.euroneuro.2004.11.001. Eur Neuropsychopharmacol. 2005. PMID: 15695071

7

Serotonin uptake to lymphocytes of patients with social phobia compared to normal individuals.

Barkan T, Hermesh H, Marom S, Gurwitz D, Weizman A, Rehavi M. Barkan T, et al. Among authors: rehavi m. Eur Neuropsychopharmacol. 2006 Jan;16(1):19-23. doi: 10.1016/j.euroneuro.2005.06.002. Epub 2005 Jul 14. Eur Neuropsychopharmacol. 2006. PMID: 16023834

8

Characterization of the serotonin transporter in lymphocytes and platelets of schizophrenia patients treated with atypical or typical antipsychotics compared to healthy individuals.

Barkan T, Peled A, Modai I, Weizman A, Rehavi M. Barkan T, et al. Among authors: rehavi m. Eur Neuropsychopharmacol. 2006 Aug;16(6):429-36. doi: 10.1016/j.euroneuro.2005.11.008. Epub 2006 Jan 20. Eur Neuropsychopharmacol. 2006. PMID: 16431091

9

Serotonin transporter characteristics in lymphocytes and platelets of male aggressive schizophrenia patients compared to non-aggressive schizophrenia patients.

Barkan T, Peled A, Modai I, Barak P, Weizman A, Rehavi M. Barkan T, et al. Among authors: rehavi m. Eur Neuropsychopharmacol. 2006 Dec;16(8):572-9. doi: 10.1016/j.euroneuro.2006.03.001. Epub 2006 May 19. Eur Neuropsychopharmacol. 2006. PMID: 16713194

10

Tricyclic antidepressants and calcium channel blockers: interactions at the (-)-desmethoxyverapamil binding site and the serotonin transporter.

Rehavi M, Carmi R, Weizman A. Rehavi M, et al. Eur J Pharmacol. 1988 Oct 11;155(1-2):1-9. doi: 10.1016/0014-2999(88)90396-2. Eur J Pharmacol. 1988. PMID: 2854066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters